1.340USD+14.53%Mkt Cap: 10.11M $P/E: —2d ago
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that i…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap10.11M $
Enterprise Value5.33M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-17.54M $
Revenue/Share—
Last Price1.340 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.26
PEG—
EV/EBITDA-0.24
EV/Revenue—
P/S—
P/B1.37
EPS (TTM)-4.23
EPS (Forward)-0.57
52W Range
0.820018% of range3.790
52W High3.790 USD
52W Low0.8200 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-92.27%
ROA-81.36%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.03M $
CapEx (TTM)—
FCF Margin—
FCF Yield-138.48%
Net Debt-8.70M $
Net Debt/EBITDA0.39
Balance Sheet
Debt/Equity0.02
Current Ratio3.59
Quick Ratio2.93
Book Value/Sh1.362 USD
Cash/Share1.190 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 22, 2019
Splits
Last Split1:10
Split DateJul 7, 2025
Analyst Consensus
Rating—
Target (Mean)5.255 USD
Upside (mean)+292.2%
Target Range5.000 USD – 5.510 USD
$5.000+292.2% to mean$5.510
# Analysts2
Ownership
Shares Out.8.45M
Float7.50M
Insiders0.30%
Institutions19.78%
Short Interest
Short Ratio3.8d
Short % Float10.67%
Short % Out.10.61%
Shares Short800.59K
Short (prev mo.)449.02K
Technical
SMA 501.656 (-19.1%)
SMA 2001.462 (-8.3%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)6.27M
Avg Vol (10d)24.54M
Technical Indicators
RSI (14)46.7
MACD-0.0878
MACD Signal-0.0835
MACD Hist.-0.0043
BB Upper1.888 USD
BB Middle1.415 USD
BB Lower0.9419 USD
BB Width66.86%
ATR (14)0.4052 USD
Vol Ratio (20d)5.62x